Rocket Pharmaceuticals, Inc.
corporate_fare Company Profile
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for RCKT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Rocket Pharmaceuticals Establishes $100M At-The-Market Offering Program, Replaces Prior Agreement
- Rocket Pharmaceuticals Launches $100M At-The-Market Offering to Boost Capital Runway
- Rocket Pharmaceuticals Files $400M Universal Shelf Registration Amidst Operational Challenges
- Rocket Pharma's Pivotal Danon Disease Trial Resumes, KRESLADI™ PDUFA Set for March 28, 2026
- Rocket Pharmaceuticals Details Major Restructuring, Clinical Trial Setbacks, and Ongoing Lawsuits in Annual Report
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$223.12M
Diluted EPS
-$2.01
Op. Cash Flow
-$190.01M
Free Cash Flow
-$190.45M
Operating Income
-$231.75M
Cash & Equivalents
$77.56M
Debt / Equity
0.00×
Shares Outstanding
108.32M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076551
show_chartPrice Chart
Loading chart...
feed RCKT - Filings & News (Page 2)
RCKT
Mar 10, 2026, 5:24 PM EDT
Price at Filing:
$5.21
Real-time Price:
$2.01
Change:
-$3.20 (-61%)
Market Cap:
$217.738M
RCKT
Mar 10, 2026, 5:19 PM EDT
Price at Filing:
$5.21
Real-time Price:
$2.01
Change:
-$3.20 (-61%)
Market Cap:
$217.738M
RCKT
Mar 02, 2026, 4:17 PM EST
Price at Filing:
$4.96
Real-time Price:
$2.01
Change:
-$2.95 (-59%)
Market Cap:
$217.738M
RCKT
Feb 26, 2026, 4:21 PM EST
Price at Filing:
$4.55
Real-time Price:
$2.01
Change:
-$2.54 (-56%)
Market Cap:
$217.738M
RCKT
Feb 26, 2026, 4:06 PM EST
Price at Filing:
$4.52
Real-time Price:
$2.01
Change:
-$2.51 (-56%)
Market Cap:
$217.738M